A. Mohammed Shefeeq

Immune-Related Adverse Events of Checkpoint Inhibitors: Clinical Spectrum and Insights Across Major Malignancies

A. Mohammed Shefeeq · Asian Journal of Immunology · 2026

Immune checkpoint inhibitors have transformed the management of solid and haematological malignancies by restoring antitumour T-cell activity through blockade of cytotoxic T-lymphocyte-associated protein 4, programmed cell death protein 1, and programmed death-ligand 1. The same...